RegeneRx Biopharmaceuticals, Inc. (NYSEMKT:RGN)
CAPS Rating:
The Company is a biopharmaceutical company that focuses on the discovery and development of novel molecules to accelerate tissue and organ repair.
The Company is a biopharmaceutical company that focuses on the discovery and development of novel molecules to accelerate tissue and organ repair.
Recs
Busted ! Cleaning up after 2 year hiatus from CAPS.